Clinical Trial Update: A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 safety study evaluating the oral netupitant/palonosetron combination for preventing chemotherapy-induced nausea and vomiting has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Netupitant (netupitant)
• Palonosetron (palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2014-11-17